“I don’t think it’s good news to have something that spreads fast,” Pfizer CEO Albert Bourla told The Wall Street Journal.
Get the daily email about stock.
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
MOST VIEWED
-
Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’
-
Biden didn’t accept Putin’s ‘red lines’ on Ukraine – here’s what that means
-
Ford partners with GlobalFoundries to increase chip supplies
-
CEOs across the market, economy agree on one big 2022 prediction: More volatility
-
Inflation is sticking around – and Biden will likely have to wait it out like the rest of us
